Detalhe da pesquisa
1.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
; 184(21): 5432-5447.e16, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619077
2.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242577
3.
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Cell
; 183(4): 1070-1085.e12, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031744
4.
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
Cell
; 183(2): 429-441.e16, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941803
5.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
6.
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Cell
; 183(5): 1367-1382.e17, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160446
7.
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Cell
; 182(2): 429-446.e14, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526206
8.
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
Nat Immunol
; 23(6): 960-970, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654851
9.
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
Immunity
; 56(3): 669-686.e7, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889306
10.
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity
; 54(8): 1869-1882.e6, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270939
11.
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.
Nature
; 599(7885): 465-470, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547765
12.
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Nature
; 591(7850): 451-457, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33561864
13.
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature
; 586(7830): 560-566, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854108
14.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
15.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
16.
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements.
PLoS Pathog
; 19(2): e1011168, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812267
17.
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies.
Mol Ther
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605519
18.
Establishing a Mouse Model for Sexual Transmission and Male Reproductive Tract Persistence of Ebola Virus.
J Infect Dis
; 228(Suppl 7): S554-S558, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102262
19.
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.
PLoS Pathog
; 17(1): e1009287, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513210
20.
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
; 117(47): 29832-29838, 2020 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139569